Home›Stock Screener›Indegene›Fair Value

Indegene Fair Value

Average Fair Value
₹490.6
Current Market Price: ₹518.9
-5.45% Price Difference

Indegene (INDGN) average fair value is ₹490.6 across 8 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹518.9 (-5.45%), fair value range ₹60.31–₹1746.07. For live price and a broader fundamental view, visit INDGN share price.

Fair Value Analysis Export

INDGN Fair Value vs Current Price — Valuation Summary

INDGN average fair value, fair value range, price gap and valuation status across 8 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF). Examine INDGN quarterly trends for recent quarterly revenue, profit and EPS trends.

Average Fair Value
₹490.6
Current Market Price
₹518.9
Price Difference
₹-28.3
Percentage Difference
-5.45%
Fair Value Range
₹60.31 - ₹1746.07
Methods Used
8
Analysis based on 8 valuation methods: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF)

P/E Based Valuation

Current EPS ₹3.32
Sector Avg P/E 20.65
Historical Avg P/E N/A
Average Fair Value
₹61.59

P/B Based Valuation

Book Value/Share ₹653.96
Sector Avg P/B 3.84
Historical Avg P/B N/A
Average Fair Value
₹1746.07

Price-to-Sales Valuation

Revenue/Share ₹42.22
Sector Avg P/S 4.0
Fair Value
₹168.87

Asset-Based Valuation

Book Value/Share ₹653.96
Liquidation Value/Share ₹673.75
Fair Value
₹653.96

Earnings Growth Model (PEG)

Current EPS ₹3.32
Growth Rate 18.17%
Fair P/E Ratio 18.17
Fair Value
₹60.31

Peter Lynch Fair Value

Current EPS ₹17.35
Growth Rate 18.17%
Dividend Yield 0.44%
Lynch Factor 18.61
Fair P/E Ratio 18.61
Data Source Quarterly Data (3 years)
Fair Value (Lynch Factor Adjusted)
₹322.83

Benjamin Graham Number

Current EPS ₹3.32
Book Value/Share ₹653.96
Graham Multiplier 22.5
Current P/E 30.51
Graham Criteria 0/3
Graham Number
₹221.02

Discounted Cash Flow (DCF)

Current FCF ₹442.0 Cr
FCF Growth Rate 26.61%
Discount Rate 10.0%
Terminal Growth 3.0%
Enterprise Value ₹16576.16 Cr
DCF Fair Value
₹690.15

INDGN Fair Value Analysis — Data Sources & Coverage

Indegene financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. See INDGN book value comparison to compare market price against book value per share.

Methods Used
8
Data Year
2026
Sector
Healthcare

Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.

Data Currency: Financial data is from the current year (2026).

INDGN vs Healthcare Sector Peers — P/E, P/B & Market Cap

Indegene P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.

Company Symbol P/E Ratio P/B Ratio Market Cap (₹ Cr)
Jeena Sikho Lifecare JSLL 40.02 22.33 ₹7,891
Accretion Pharmaceuticals ACCPL 13.72 2.43 ₹131
Par Drugs & Chemical PAR 8.67 1.01 ₹111
Auro Laboratories AUROLAB 91.49 3.91 ₹165
Murae Organisor MURAE 2.86 0.2 ₹41

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.